1. G.d. Searle & Company (52 from 1,323 patents)

2. Pharmacia Corporation (30 from 220 patents)

3. Monsanto Company (23 from 3,288 patents)

4. G.d. Searle LLC (8 from 33 patents)

5. Atherogenics, Inc. (8 from 25 patents)

6. Pfizer Corporation (6 from 4,455 patents)

7. Salutria Pharmaceuticals LLC (1 from 4 patents)

8. Pharmacia Corporation Global Patent Department (1 from 1 patent)

9. G. D. Dearle & Co. (1 from 1 patent)

1. 7897776 - Sulfonamide containing compounds for treatment of inflammatory disorders

2. 7339078 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

3. 7297793 - Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors

4. 7273948 - Process of preparing esters and ethers of probucol and derivatives thereof

5. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

6. 7202247 - 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders

7. 7183317 - Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality

8. 7173129 - Sulfonamide-substituted chalcone derivatives and their use to treat diseases

9. 7161033 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

10. 7141594 - Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

11. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

12. 7098202 - Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

13. 7094801 - Chalcone derivatives and their use to treat diseases

14. 7091219 - Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors

15. 7078431 - 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders